Diabetes Research Today is a free monthly online journal that collates and summarizes the latest research about Diabetes, including details on insulin, type i, type ii, diet, treatment, prevention.

Volume 4 (2007), Issue 12 (December)

1. Plasma ghrelin concentrations in type 1 diabetic patients with autoimmune atrophic gastritis.
   Eur J Endocrinol, 157(6): 763-9. [Abstract] [Full-text]
2. Differences in the quality of primary medical care services by remoteness from urban settlements.
   Qual Saf Health Care, 16(6): 446-9. [Abstract] [Full-text]
3. Intravitreal triamcinolone plus sequential grid laser versus triamcinolone or laser alone for treating diabetic macular edema: six-month outcomes.
   Ophthalmology, 114(12): 2162-7. [Abstract] [Full-text]
4. Determinants of progression of coronary artery calcification in type 2 diabetes role of glycemic control and inflammatory/vascular calcification markers.
   J Am Coll Cardiol, 50(23): 2218-25. [Abstract] [Full-text]
5. Coma with diffuse white matter hemorrhages in juvenile diabetic ketoacidosis.
   Pediatrics, 120(6): e1540-6. [Abstract] [Full-text]
6. Infrequently studied congenital anomalies as clues to the diagnosis of maternal diabetes mellitus.
   Am J Med Genet A, 143(24): 2904-9. [Abstract] [Full-text]
7. Association of the PIK3C2G gene polymorphisms with type 2 DM in a Japanese population.
   Biochem Biophys Res Commun, 365(3): 466-71. [Abstract] [Full-text]
8. Incidence of new stroke or new myocardial infarction or death at 39-month follow-up in patients with diabetes mellitus, hypertension or both with and without microalbuminuria.
   Cardiology, 109(1): 62-5. [Abstract] [Full-text]
9. Evaluation of the impact of the Kuwait Diabetes Care Program on the quality of diabetes care.
   Med Princ Pract, 17(1): 14-9. [Abstract] [Full-text]
10. Pregabalin for relief of neuropathic pain associated with diabetic neuropathy: a randomized, double-blind study.
    Eur J Pain, 12(2): 203-13. [Abstract] [Full-text]
11. Localization of type 1 diabetes susceptibility to the MHC class I genes HLA-B and HLA-A.
    Nature, 450(7171): 887-92. [Abstract] [Full-text]
12. Can rodent models of diabetic kidney disease clarify the significance of early hyperfiltration?: recognizing clinical and experimental uncertainties.
    Clin Sci (Lond), 114(2): 109-18. [Abstract] [Full-text]
13. The use of CD3-specific antibodies in autoimmune diabetes: a step toward the induction of immune tolerance in the clinic.
    Handb Exp Pharmacol. [Abstract] [Full-text]
14. Active smoking and the risk of type 2 diabetes: a systematic review and meta-analysis.
    JAMA, 298(22): 2654-64. [Abstract] [Full-text]
15. Thiazolidinediones and cardiovascular outcomes in older patients with diabetes.
    JAMA, 298(22): 2634-43. [Abstract] [Full-text]
16. Discovery of potent and specific fructose-1,6-bisphosphatase inhibitors and a series of orally-bioavailable phosphoramidase-sensitive prodrugs for the treatment of type 2 diabetes.
    J Am Chem Soc, 129(50): 15491-502. [Abstract] [Full-text]
17. Severe symptoms of gastro-oesophageal reflux disease are associated with cardiovascular disease and other gastrointestinal symptoms, but not diabetes: a population-based study.
    Aliment Pharmacol Ther, 27(1): 58-65. [Abstract] [Full-text]
18. Effects of clopidogrel and aspirin in combination versus aspirin alone on platelet activation and major receptor expression in diabetic patients: the PLavix Use for Treatment Of Diabetes (PLUTO-Diabetes) trial.
    Am Heart J, 155(1): 93.e1-7. [Abstract] [Full-text]
19. Rationale, design, and baseline characteristics for a large international trial of cardiovascular disease prevention in people with dysglycemia: the ORIGIN Trial (Outcome Reduction with an Initial Glargine Intervention).
    Am Heart J, 155(1): 26-32, 32.e1-6. [Abstract] [Full-text]
20. Diabetes mellitus following gestational diabetes: role of subsequent pregnancy.
    BJOG, 115(2): 253-9; discussion 260. [Abstract] [Full-text]
21. Antisense inhibition of 11betahydroxysteroid dehydrogenase type 1 improves diabetes in a novel cortisone-induced diabetic KK mouse model.
    Biochem Biophys Res Commun, 365(4): 740-5. [Abstract] [Full-text]
22. Adaptation to hypoxia in the diabetic rat kidney.
    Kidney Int, 73(1): 34-42. [Abstract] [Full-text]
23. The new insulins.
    Pediatr Emerg Care, 23(12): 903-5; quiz 906-7. [Abstract] [Full-text]
24. Unsuspected osteomyelitis is frequent in persistent diabetic foot ulcer and better diagnosed by MRI than by 18F-FDG PET or 99mTc-MOAB.
    J Intern Med, 263(1): 99-106. [Abstract] [Full-text]
25. 1,5-anhydroglucitol (GlycoMark) as a marker of short-term glycemic control and glycemic excursions.
    Expert Rev Mol Diagn, 8(1): 9-19. [Abstract] [Full-text]
26. The contribution of teleconsultation and videoconferencing to diabetes care: a systematic literature review.
    J Med Internet Res, 9(5): e37. [Abstract] [Full-text]
27. Interest in the use of computerized patient portals: role of the provider-patient relationship.
    J Gen Intern Med, 23: 20-6. [Abstract] [Full-text]
28. Effects of generated trans-arachidonic acids on retinal capillary during nitrative stress in diabetic rats.
    Ophthalmologica, 222(1): 37-41. [Abstract] [Full-text]
29. The status of diabetic retinopathy and diabetic macular edema in patients with type 2 diabetes: a survey from Beixinjing District of Shanghai city in China.
    Ophthalmologica, 222(1): 32-6. [Abstract] [Full-text]
30. Update: vildagliptin for the treatment of Type 2 diabetes.
    Expert Opin Investig Drugs, 17(1): 105-13. [Abstract] [Full-text]
31. Blood lead levels, malnutrition, inflammation, and mortality in patients with diabetes treated by long-term hemodialysis.
    Am J Kidney Dis, 51(1): 107-15. [Abstract] [Full-text]
32. Risk factors for development and progression of diabetic kidney disease and treatment patterns among diabetic siblings of patients with diabetic kidney disease.
    Am J Kidney Dis, 51(1): 29-37. [Abstract] [Full-text]
33. Blood into beta-cells: can adult stem cells be used as a therapy for Type 1 diabetes?
    Regen Med, 3(1): 33-47. [Abstract] [Full-text]
34. Intravitreal triamcinolone versus bevacizumab for treatment of refractory diabetic macular oedema (IBEME study).
    Br J Ophthalmol, 92(1): 76-80. [Abstract] [Full-text]
35. Vision-related quality of life in patients with diabetic macular oedema.
    Br J Ophthalmol, 92(1): 89-92. [Abstract] [Full-text]
36. The predictive value of patient and eye characteristics on the course of subclinical diabetic macular edema.
    Am J Ophthalmol, 145(1): 149-154. [Abstract] [Full-text]
37. Association between androgen-deprivation therapy and incidence of diabetes among males with prostate cancer.
    Urology, 70(6): 1104-8. [Abstract] [Full-text]
38. Involvement of the Rho/Rho kinase signaling pathway in platelet-derived growth factor BB-induced vascular endothelial growth factor expression in diabetic rat retina.
    Jpn J Ophthalmol, 51(6): 424-30. [Abstract] [Full-text]
39. Protection of pancreatic beta-cells: is it feasible?
    Nutr Metab Cardiovasc Dis, 18(1): 74-83. [Abstract] [Full-text]
40. A study on the action of vitamin E supplementation on plasminogen activator inhibitor type 1 and platelet nitric oxide production in type 2 diabetic patients.
    Nutr Metab Cardiovasc Dis, 18(1): 15-22. [Abstract] [Full-text]
41. Interaction between the uncoupling protein 2 -866G>A gene variant and cigarette smoking to increase oxidative stress in subjects with diabetes.
    Nutr Metab Cardiovasc Dis, 18(1): 7-14. [Abstract] [Full-text]
42. Non-traditional markers of atherosclerosis potentiate the risk of coronary heart disease in patients with type 2 diabetes and metabolic syndrome.
    Nutr Metab Cardiovasc Dis, 18(1): 31-8. [Abstract] [Full-text]
43. Changes over time in the prevalence and quality of care of type 2 diabetes in Italy: the Casale Monferrato surveys, 1988 and 2000.
    Nutr Metab Cardiovasc Dis, 18(1): 39-45. [Abstract] [Full-text]
44. Modulation of CD36 protein expression by AGEs and insulin in aortic VSMCs from diabetic and non-diabetic rats.
    Nutr Metab Cardiovasc Dis, 18(1): 23-30. [Abstract] [Full-text]
45. Circulating homocysteine levels in patients with type 2 diabetes mellitus.
    Nutr Metab Cardiovasc Dis, 18(1): 66-73. [Abstract] [Full-text]
46. Korean red ginseng (Panax ginseng) improves glucose and insulin regulation in well-controlled, type 2 diabetes: results of a randomized, double-blind, placebo-controlled study of efficacy and safety.
    Nutr Metab Cardiovasc Dis, 18(1): 46-56. [Abstract] [Full-text]
47. Quality of diabetes care predicts the development of cardiovascular events: results of the QuED study.
    Nutr Metab Cardiovasc Dis, 18(1): 57-65. [Abstract] [Full-text]
48. Adverse pregnancy outcome in women with mild glucose intolerance: is there a clinically meaningful threshold value for glucose?
    Acta Obstet Gynecol Scand, 87(1): 59-62. [Abstract] [Full-text]
49. Factors influencing pregnancy outcome in women with type 2 versus type 1 diabetes mellitus.
    Acta Obstet Gynecol Scand, 87(1): 43-9. [Abstract] [Full-text]
50. Trends and disparities among diabetes-complicated births in Minnesota, 1993-2003.
    Am J Public Health, 98(1): 59-62. [Abstract] [Full-text]
51. Vitreous fluid of db/db mice exhibits alterations in angiogenic and metabolic factors consistent with early diabetic retinopathy.
    Ophthalmic Res, 40(1): 5-9. [Abstract] [Full-text]
52. Type 2 diabetes-associated fatty acid binding protein 2 promoter haplotypes are differentially regulated by GATA factors.
    Hum Mutat, 29(1): 142-9. [Abstract] [Full-text]
53. Genome-wide scan for estimated glomerular filtration rate in multi-ethnic diabetic populations: the Family Investigation of Nephropathy and Diabetes (FIND).
    Diabetes, 57(1): 235-43. [Abstract] [Full-text]
54. Impact of common type 2 diabetes risk polymorphisms in the DESIR prospective study.
    Diabetes, 57(1): 244-54. [Abstract] [Full-text]
55. Unaltered diabetes presentation in NOD mice lacking the vitamin D receptor.
    Diabetes, 57(1): 269-75. [Abstract] [Full-text]
56. Electronegative LDL impairs vascular endothelial cell integrity in diabetes by disrupting fibroblast growth factor 2 (FGF2) autoregulation.
    Diabetes, 57(1): 158-66. [Abstract] [Full-text]
57. Insulin resistance and progression to type 1 diabetes in the European Nicotinamide Diabetes Intervention Trial (ENDIT).
    Diabetes Care, 31(1): 146-50. [Abstract] [Full-text]
58. Increased risks of hip fracture in diabetic patients of Taiwan: a population-based study.
    Diabetes Care, 31(1): 75-80. [Abstract] [Full-text]
59. Low physical activity accentuates the effect of the FTO rs9939609 polymorphism on body fat accumulation.
    Diabetes, 57(1): 95-101. [Abstract] [Full-text]
60. Mosaic paternal uniparental isodisomy and an ABCC8 gene mutation in a patient with permanent neonatal diabetes and hemihypertrophy.
    Diabetes, 57(1): 255-8. [Abstract] [Full-text]
61. Five-year impact of a continuous quality improvement effort implemented by a network of diabetes outpatient clinics.
    Diabetes Care, 31(1): 57-62. [Abstract] [Full-text]
62. Nonobese diabetic (NOD) mice congenic for a targeted deletion of 12/15-lipoxygenase are protected from autoimmune diabetes.
    Diabetes, 57(1): 199-208. [Abstract] [Full-text]
63. Insulin resistance of protein metabolism in type 2 diabetes.
    Diabetes, 57(1): 56-63. [Abstract] [Full-text]
64. Sex disparities in control and treatment of modifiable cardiovascular disease risk factors among patients with diabetes: Translating Research Into Action for Diabetes (TRIAD) Study.
    Diabetes Care, 31(1): 69-74. [Abstract] [Full-text]
65. Prediction of healing for postoperative diabetic foot wounds based on early wound area progression.
    Diabetes Care, 31(1): 26-9. [Abstract] [Full-text]
66. Reevaluating the way we classify the diabetic foot: restructuring the diabetic foot risk classification system of the International Working Group on the Diabetic Foot.
    Diabetes Care, 31(1): 154-6. [Abstract] [Full-text]
67. Is glycemic control improving in U.S. adults?
    Diabetes Care, 31(1): 81-6. [Abstract] [Full-text]
68. A variant of the transcription factor 7-like 2 (TCF7L2) gene and the risk of posttransplantation diabetes mellitus in renal allograft recipients.
    Diabetes Care, 31(1): 63-8. [Abstract] [Full-text]
69. Disorders of glucose regulation in adults and birth weight: results from the Australian Diabetes, Obesity and Lifestyle (AUSDIAB) Study.
    Diabetes Care, 31(1): 159-64. [Abstract] [Full-text]
70. Liver fat is increased in type 2 diabetic patients and underestimated by serum alanine aminotransferase compared with equally obese nondiabetic subjects.
    Diabetes Care, 31(1): 165-9. [Abstract] [Full-text]
71. Reduced vascular endothelial growth factor expression and intra-epidermal nerve fiber loss in human diabetic neuropathy.
    Diabetes Care, 31(1): 140-5. [Abstract] [Full-text]
72. Prevalence of depression among U.S. adults with diabetes: findings from the 2006 behavioral risk factor surveillance system.
    Diabetes Care, 31(1): 105-7. [Abstract] [Full-text]
73. Reduction in diabetic amputations over 11 years in a defined U.K. population: benefits of multidisciplinary team work and continuous prospective audit.
    Diabetes Care, 31(1): 99-101. [Abstract] [Full-text]
74. Further evidence of a primary, causal association of the PTPN22 620W variant with type 1 diabetes.
    Diabetes, 57(1): 229-34. [Abstract] [Full-text]
75. Inactivation of glyceraldehyde-3-phosphate dehydrogenase by fumarate in diabetes: formation of S-(2-succinyl)cysteine, a novel chemical modification of protein and possible biomarker of mitochondrial stress.
    Diabetes, 57(1): 41-9. [Abstract] [Full-text]
76. MT1-MMP expression in first-trimester placental tissue is upregulated in type 1 diabetes as a result of elevated insulin and tumor necrosis factor-alpha levels.
    Diabetes, 57(1): 150-7. [Abstract] [Full-text]
77. Functional waning of naturally occurring CD4+ regulatory T-cells contributes to the onset of autoimmune diabetes.
    Diabetes, 57(1): 113-23. [Abstract] [Full-text]
78. Endothelial dysfunction and C-reactive protein are risk factors for diabetes in essential hypertension.
    Diabetes, 57(1): 167-71. [Abstract] [Full-text]
79. Insulin reduces plasma arginase activity in type 2 diabetic patients.
    Diabetes Care, 31(1): 134-9. [Abstract] [Full-text]
80. Prevalence of diabetes and impaired fasting glucose in the adult population of Iran: National Survey of Risk Factors for Non-Communicable Diseases of Iran.
    Diabetes Care, 31(1): 96-8. [Abstract] [Full-text]
81. Determinants of whole-body protein metabolism in subjects with and without type 2 diabetes.
    Diabetes Care, 31(1): 128-33. [Abstract] [Full-text]
82. Comparison of the effects of pioglitazone and metformin on hepatic and extra-hepatic insulin action in people with type 2 diabetes.
    Diabetes, 57(1): 24-31. [Abstract] [Full-text]
83. Multiple superoxide dismutase 1/splicing factor serine alanine 15 variants are associated with the development and progression of diabetic nephropathy: the Diabetes Control and Complications Trial/Epidemiology of Diabetes Interventions and Complications Genetics study.
    Diabetes, 57(1): 218-28. [Abstract] [Full-text]
84. Fatty acids and insulin modulate myocardial substrate metabolism in humans with type 1 diabetes.
    Diabetes, 57(1): 32-40. [Abstract] [Full-text]
85. Relationship of polyunsaturated fatty acid intake to peripheral neuropathy among adults with diabetes in the National Health and Nutrition Examination Survey (NHANES) 1999 2004.
    Diabetes Care, 31(1): 93-5. [Abstract] [Full-text]
86. Expression of NG,NG-dimethylarginine dimethylaminohydrolase and protein arginine N-methyltransferase isoforms in diabetic rat kidney: effects of angiotensin II receptor blockers.
    Diabetes, 57(1): 172-80. [Abstract] [Full-text]
87. Neuritin mediates nerve growth factor-induced axonal regeneration and is deficient in experimental diabetic neuropathy.
    Diabetes, 57(1): 181-9. [Abstract] [Full-text]
88. Hypoglycemia in pregnant women with type 1 diabetes: predictors and role of metabolic control.
    Diabetes Care, 31(1): 9-14. [Abstract] [Full-text]
89. Head-to-head comparison of sirolimus- and paclitaxel-eluting stent in the same diabetic patient with multiple coronary artery lesions: a prospective, randomized, multicenter study.
    Diabetes Care, 31(1): 15-9. [Abstract] [Full-text]
90. Ten-year trends in self-rated health among Spanish adults with diabetes, 1993 2003.
    Diabetes Care, 31(1): 90-2. [Abstract] [Full-text]
91. Addition of pioglitazone and ramipril to intensive insulin therapy in type 2 diabetic patients improves vascular dysfunction by different mechanisms.
    Diabetes Care, 31(1): 121-7. [Abstract] [Full-text]
92. Homocysteine and diabetic retinopathy.
    Diabetes Care, 31(1): 50-6. [Abstract] [Full-text]
93. Expression of matrix metalloproteinases, cytokines, and connexins in diabetic and nondiabetic human keratinocytes before and after transplantation into an ex vivo wound-healing model.
    Diabetes Care, 31(1): 114-20. [Abstract] [Full-text]

© 2004-2008 Diabetes Research Today. All Rights Reserved.